Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 08, 2018

SELL
$3.39 - $4.61 $847 - $1,152
-250 Closed
0 $0
Q2 2018

Aug 03, 2018

BUY
$1.89 - $4.95 $472 - $1,237
250 New
250 $1,000
Q4 2017

Feb 08, 2018

SELL
$1.91 - $2.83 $4,775 - $7,075
-2,500 Closed
0 $0
Q3 2017

Nov 06, 2017

BUY
$2.44 - $2.91 $6,100 - $7,275
2,500
2,500 $7,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0

About MEI Pharma, Inc.


  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $366M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.